Loading…

Epigral approved entry into epoxy resin and formulations business with a planned capacity of 125,000 tonnes per annum and a multi-purpose plant, with a total investment of ₹600 crore. Both projects are expected to be commissioned in H2 FY28.
“Epigral approved its entry into the Epoxy Resin & Formulations business with a planned production capacity of 1,25,000 tonnes per annum, along with the setting up of a Multi-Purpose Plant (MPP).”cnbctv18.com
Summarized from public sources; check the original articles before acting on it.